Lung malignancies after Hodgkin lymphoma: Disease characteristics, detection methods and clinical outcome

Annals of Oncology

Volumn 23, Issue 7, 2012, Pages 1813-1818

  Schoenfeld, J D ^a   Mauch, P M ^a,b   Das, P ^c   Silver, B ^a,b   Marcus, K J ^a,b,d   Stevenson, M A ^e   Ng, A K ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Detection; Hodgkin lymphoma; Lung cancer; Screening; Second malignancy; Thoracic neoplasm

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOLOGY; HODGKIN DISEASE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMOKING; SURVIVAL TIME; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENTAL FINDINGS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84864300268     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr551     Document Type: Article

References (31)

1. Armitage JO. Early-stage Hodgkin's lymphoma. N Engl J Med 2010; 363: 653-662.
2. Aleman BMP, van den Belt-Dusebout AW, Klokman WJ et al. Long-term causespecific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003; 21: 3431-3439.
3. Castellino SM, Geiger AM, Mertens AC et al. Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 2011; 117: 1806-1816.
4. Ng AK, Bernardo MP, Weller E et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002; 20: 2101-2108.
5. Lorrigan P, Radford J, Howell A et al. Lung cancer after treatment for Hodgkin's lymphoma: a systematic review. Lancet Oncol 2005; 6: 773-779.
6. Travis LB, Gospodarowicz M, Curtis RE et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease. J Natl Cancer Inst 2002; 94: 182-192.
7. Nyandoto P, Muhonen T, Joensuu H. Second cancer among long-term survivors from Hodgkin's disease. Int J Radiat Oncol Biol Phys 1998; 42: 373-378.
8. van Leeuwen FE, Klokman WJ, Stovall M et al. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease. J Natl Cancer Inst 1995; 87: 1530-1537.
9. van Leeuwen FE, Klokman WJ, Hagenbeek A et al. Second cancer risk following Hodgkin's disease: a 20 year follow-up study. J Clin Oncol 1994; 12: 312-325.
10. Henry-Amar M. Second cancer after the treatment for Hodgkin's disease: a report from the international database on Hodgkin's disease. Ann Oncol 1992; 3 (Suppl 4): 117-128.
11. Kaldor JM, Day NE, Bell J et al. Lung cancer following Hodgkin's disease: a case-control study. Int J Cancer 1992; 52: 677-681.
12. Swerdlow AJ, Barber JA, Hudson GV et al. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol 2000; 18: 498-509.
13. Swerdlow AJ, Schoemaker MJ, Allerton R et al. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. J Clin Oncol 2001; 19: 1610-1618.
14. Swerdlow AJ, Higgins CD, Smith P et al. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a Collaborative British Cohort Study. J Clin Oncol 2011 29: 4096-4104.
15. Behringer K, Josting A, Schiller P et al. Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group. Ann Oncol 2004; 15: 1079-1085.
16. Das P, Ng AK, Stevenson MA et al. Clinical course of thoracic cancers in Hodgkin's disease survivors. Ann Oncol 2005; 16: 793-797.
17. Laurie SA, Kris MG, Portlock CS et al. The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease. Cancer 2002; 95: 119-126.
18. Kaplan EM, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
19. Milano MT, Li HL, Constine LS et al. Survival after second primary lung cancer: a population based study of 187 Hodgkins lymphoma patients. Cancer 2011; [epub ahead of print], doi:10.1002/cncr.26257.
20. Ng A, Constine LS, Advani R et al. ACR Appropriateness Criteria: follow-up of Hodgkin's lymphoma. Curr Probl Cancer 2010; 34: 211-227.
21. Henschke CI, Boffetta P, Gorlova O et al. Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer 2011; 71: 328-332.
22. Henschke CI, Yankelevitz DF et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006; 355: 1763-1771.
23. Pastorino U, Bellomi M, Landoni C et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003; 362: 593-597.
24. National Lung Screening Trial Research TeamReduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365: 395-409.
25. Das P, Ng AK, Earle CC et al. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. Ann Oncol 2006; 17: 785-793.
26. Hodgson DC, Koh E-S, Tran TH et al. Individualized estimates of second cancer risks after contemporary radiation therapy for Hodgkin lymphoma. Cancer 2007; 110: 2576-2586.
27. Engert A, Plütschow A, Eich HT et al. Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med 2010; 363: 640-652.
28. Fermé C, Eghbali H, Meerwaldt JH et al. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. N Engl J Med 2007; 357: 1916-1927.
29. Bonadonna G, Bonfante V, Viviani S et al. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results. J Clin Oncol 2004; 22: 2835-2841.
30. Paumier A, Ghalibafian M, Beaudre A et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2011; 80: 199-205.
31. Ng AK, Lacasce A, Travis LB. Long-term complications of lymphoma and its treatment. J Clin Oncol 2011; 29: 1885-1892.